Crispr Therapeutics Ag (CRSP)

$55.56 2.40 (4.14%)

16:00 EDT CRSP Stock Quote Delayed 30 Minutes

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

3 Biopharma Stocks Predicted to Soar in Q2 2024

The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024

Volume:

Previous Close -

Market Cap 4.39B

PE Ratio -82.93

EPS -0.67

Volume (Avg. Vol.) 1.41M

Day's Range $55.52 - $58.47

52-Week Range $37.55 - $91.10

Dividend & Yield N/A (N/A)

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

From InvestorPlace
From the Web

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

By Josh Enomoto, InvestorPlace Contributor Mar 13, 2024

While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table…

The Top 3 Biotech Stocks to Buy in March 2024

By Chris Markoch, InvestorPlace Contributor Mar 6, 2024

Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

By Viktor Zarev, InvestorPlace Contributor Mar 4, 2024

Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.

3 Biotech Stocks Bound to Blast Off By 2029

By Chandler Capital, InvestorPlace Contributor Feb 27, 2024

Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.

3 Stocks That Cathie Wood Is Loving Now: February 2024

By Tezcan Gecgil, InvestorPlace Contributor Feb 16, 2024

Looking for high-growth opportunities? Here are three Cathie Wood stocks for long-term investors to consider now.

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains

By Faizan Farooque, InvestorPlace Contributor Feb 11, 2024

The health sector has two things to offer: new ideas and consistent returns. As a result, healthcare stocks will continue to be a good choice…

Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements

By Faizan Farooque, InvestorPlace Contributor Feb 1, 2024

Your ultimate guide to investing in healthcare stocks in 2024. Learn about the most promising healthcare companies, market forecasts, and investment strategies tailored for you.

3 Under-the-Radar Tech Stocks With 250% Growth Potential by 2026

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 19, 2024

Discover the trailblazing strategies of three tech stocks that are reshaping industries through innovation, adaptability and revenue surges.

7 Healthcare Stocks Taking Medicine to the Next Level

By Josh Enomoto, InvestorPlace Contributor Jan 14, 2024

While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio.…

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

By Jeremy Flint, InvestorPlace Contributor Jan 3, 2024

Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

AI and Automation Leaders for 2024: 7 Stocks to Stay Ahead of the Robot Uprising

By Josh Enomoto, InvestorPlace Contributor Dec 30, 2023

It’s time for investors to ditch the search for the mythical crystal ball and instead embrace the algorithms when deciphering the best AI stock for…

3 Healthcare Technology Stocks to Improve Lives in 2024

By Jeremy Flint, InvestorPlace Contributor Dec 25, 2023

Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief

By Dana Blankenhorn, InvestorPlace Contributor Dec 20, 2023

The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.

3 Genomics Stocks to Unlock the Future of Medicine

By Jeremy Flint, InvestorPlace Contributor Dec 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

By John Blankenhorn, InvestorPlace Contributor Dec 15, 2023

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

3 Small-Cap Stocks That Could Skyrocket 1000% by 2030

By Terel Miles, InvestorPlace Contributor Dec 14, 2023

With the iShares Russell 2000 ETF (NYSE:IWM) on the move, investors should consider these small-cap stocks to buy.

3 Gene-Editing Stocks With the Potential to Mint Millionaires

By Alex Sirois, InvestorPlace Contributor Dec 13, 2023

Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.

Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy

By Larry Ramer, InvestorPlace Contributor Dec 7, 2023

These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.

3 Biotech Stocks That Could Be Multibaggers in the Making

By Muslim Farooque, InvestorPlace Contributor Nov 30, 2023

Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments.

Google’s Bard AI Says These 3 Stocks Will Rise 1,000%

By Omor Ibne Ehsan Nov 20, 2023

Google's Bard has been among the best stock pickers, and thinks these three stocks have quadruple-digit upside potential.

Crispr Therapeutics Ag (CRSP)

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

3 Biopharma Stocks Predicted to Soar in Q2 2024

The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Crispr Therapeutics Ag (CRSP)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

Subscriber Sign in